United Therapeutics (UTHR) Q4 Earnings & Sales Miss, Stock Down

United Therapeutics (UTHR) fourth-quarter earnings and sales miss estimates. Higher sales of Tyvaso and Unituxin mainly drive the top line in the quarter, offset by lower sales of other drugs.

Leave a comment

Your email address will not be published. Required fields are marked *